Difference between revisions of "NtdC"
Raphael2215 (talk | contribs) |
|||
Line 1: | Line 1: | ||
− | * '''Description:''' | + | * '''Description:''' NAD-dependent glucose-6-phosphate dehydrogenase <br/><br/> |
{| align="right" border="1" cellpadding="2" | {| align="right" border="1" cellpadding="2" | ||
|- | |- | ||
Line 9: | Line 9: | ||
|style="background:#ABCDEF;" align="center"| '''Essential''' || no | |style="background:#ABCDEF;" align="center"| '''Essential''' || no | ||
|- | |- | ||
− | |style="background:#ABCDEF;" align="center"| '''Product''' || | + | |style="background:#ABCDEF;" align="center"| '''Product''' || NAD-dependent glucose-6-phosphate dehydrogenase |
|- | |- | ||
− | |style="background:#ABCDEF;" align="center"|'''Function''' || synthesis of the antibiotic | + | |style="background:#ABCDEF;" align="center"|'''Function''' || synthesis of the antibiotic kanosamine |
|- | |- | ||
|colspan="2" style="background:#FAF8CC;" align="center"| '''Gene expression levels in [http://cellpublisher.gobics.de/subtiexpress/ ''Subti''Express]''': [http://cellpublisher.gobics.de/subtiexpress/bsu/BSU10530 ntdC] | |colspan="2" style="background:#FAF8CC;" align="center"| '''Gene expression levels in [http://cellpublisher.gobics.de/subtiexpress/ ''Subti''Express]''': [http://cellpublisher.gobics.de/subtiexpress/bsu/BSU10530 ntdC] | ||
Line 36: | Line 36: | ||
<br/><br/><br/><br/> | <br/><br/><br/><br/> | ||
<br/><br/><br/><br/> | <br/><br/><br/><br/> | ||
− | |||
− | |||
− | |||
− | |||
<br/><br/> | <br/><br/> | ||
Line 73: | Line 69: | ||
* '''Catalyzed reaction/ biological activity:''' | * '''Catalyzed reaction/ biological activity:''' | ||
+ | ** glucose-6-phosphate + NAD --> 3-oxo-d-glucose-6-phosphate + NADH(2) {{PubMed|23586652}} | ||
* '''Protein family:''' gfo/idh/mocA family (according to Swiss-Prot) | * '''Protein family:''' gfo/idh/mocA family (according to Swiss-Prot) | ||
Line 87: | Line 84: | ||
* '''Cofactor(s):''' | * '''Cofactor(s):''' | ||
+ | ** NAD(+) {{PubMed|23586652}} | ||
* '''Effectors of protein activity:''' | * '''Effectors of protein activity:''' | ||
Line 112: | Line 110: | ||
* '''Expression browser:''' [http://genome.jouy.inra.fr/cgi-bin/seb/viewdetail.py?id=ntdC_1126400_1127452_-1 ntdC] {{PubMed|22383849}} | * '''Expression browser:''' [http://genome.jouy.inra.fr/cgi-bin/seb/viewdetail.py?id=ntdC_1126400_1127452_-1 ntdC] {{PubMed|22383849}} | ||
− | * '''Sigma factor:''' [[SigA]] {{PubMed|14612444}} | + | * '''[[Sigma factor]]:''' [[SigA]] {{PubMed|14612444}} |
* '''Regulation:''' induced by 3,3'-neotrehalosadiamine ([[NtdR]]) {{PubMed|14612444}} | * '''Regulation:''' induced by 3,3'-neotrehalosadiamine ([[NtdR]]) {{PubMed|14612444}} | ||
Line 142: | Line 140: | ||
<pubmed> 21512256</pubmed> | <pubmed> 21512256</pubmed> | ||
==Original publications== | ==Original publications== | ||
− | <pubmed>19087206,17056753 ,14612444 </pubmed> | + | <pubmed>19087206,17056753 ,14612444 23586652 </pubmed> |
[[Category:Protein-coding genes]] | [[Category:Protein-coding genes]] |
Revision as of 13:37, 19 April 2013
- Description: NAD-dependent glucose-6-phosphate dehydrogenase
Gene name | ntdC |
Synonyms | yhjJ |
Essential | no |
Product | NAD-dependent glucose-6-phosphate dehydrogenase |
Function | synthesis of the antibiotic kanosamine |
Gene expression levels in SubtiExpress: ntdC | |
MW, pI | 39 kDa, 6.227 |
Gene length, protein length | 1050 bp, 350 aa |
Immediate neighbours | glcP, ntdB |
Get the DNA and protein sequences (Barbe et al., 2009) | |
Genetic context This image was kindly provided by SubtiList
| |
Expression at a glance PubMed |
Contents
Categories containing this gene/protein
miscellaneous metabolic pathways, biosynthesis of antibacterial compounds
This gene is a member of the following regulons
The gene
Basic information
- Locus tag: BSU10530
Phenotypes of a mutant
Database entries
- DBTBS entry: [1]
- SubtiList entry: [2]
Additional information
The protein
Basic information/ Evolution
- Catalyzed reaction/ biological activity:
- glucose-6-phosphate + NAD --> 3-oxo-d-glucose-6-phosphate + NADH(2) PubMed
- Protein family: gfo/idh/mocA family (according to Swiss-Prot)
Extended information on the protein
- Kinetic information:
- Domains:
- Modification:
- Cofactor(s):
- NAD(+) PubMed
- Effectors of protein activity:
Database entries
- Structure:
- UniProt: O07564
- KEGG entry: [3]
- E.C. number:
Additional information
Expression and regulation
- Additional information:
Biological materials
- Mutant:
- Expression vector:
- lacZ fusion:
- GFP fusion:
- two-hybrid system:
- Antibody:
Labs working on this gene/protein
Your additional remarks
References
Reviews
Original publications
Natasha D Vetter, David M Langill, Shazia Anjum, Julie Boisvert-Martel, Rajendra C Jagdhane, Egiroh Omene, Hongyan Zheng, Karin E van Straaten, Isaac Asiamah, Ed S Krol, David A R Sanders, David R J Palmer
A previously unrecognized kanosamine biosynthesis pathway in Bacillus subtilis.
J Am Chem Soc: 2013, 135(16);5970-3
[PubMed:23586652]
[WorldCat.org]
[DOI]
(I p)
Takashi Inaoka, Takenori Satomura, Yasutaro Fujita, Kozo Ochi
Novel gene regulation mediated by overproduction of secondary metabolite neotrehalosadiamine in Bacillus subtilis.
FEMS Microbiol Lett: 2009, 291(2);151-6
[PubMed:19087206]
[WorldCat.org]
[DOI]
(I p)
Takashi Inaoka, Kozo Ochi
Glucose uptake pathway-specific regulation of synthesis of neotrehalosadiamine, a novel autoinducer produced in Bacillus subtilis.
J Bacteriol: 2007, 189(1);65-75
[PubMed:17056753]
[WorldCat.org]
[DOI]
(P p)
Takashi Inaoka, Kosaku Takahashi, Hiroshi Yada, Mitsuru Yoshida, Kozo Ochi
RNA polymerase mutation activates the production of a dormant antibiotic 3,3'-neotrehalosadiamine via an autoinduction mechanism in Bacillus subtilis.
J Biol Chem: 2004, 279(5);3885-92
[PubMed:14612444]
[WorldCat.org]
[DOI]
(P p)